VENTURA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.831
EU - Europa 17.326
AS - Asia 9.820
SA - Sud America 1.486
AF - Africa 207
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 17
Totale 48.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.470
IT - Italia 5.298
GB - Regno Unito 4.825
SG - Singapore 2.983
SE - Svezia 2.826
CN - Cina 2.753
HK - Hong Kong 1.135
BR - Brasile 1.132
DE - Germania 1.074
VN - Vietnam 1.061
FI - Finlandia 636
FR - Francia 624
UA - Ucraina 568
TR - Turchia 400
RU - Federazione Russa 397
KR - Corea 351
NL - Olanda 284
IN - India 281
CA - Canada 189
BG - Bulgaria 178
ID - Indonesia 138
AR - Argentina 135
BD - Bangladesh 119
MX - Messico 104
PL - Polonia 99
IQ - Iraq 89
BE - Belgio 80
JP - Giappone 75
ZA - Sudafrica 73
IE - Irlanda 69
ES - Italia 60
MY - Malesia 53
AE - Emirati Arabi Uniti 52
EC - Ecuador 46
CH - Svizzera 42
RO - Romania 40
CO - Colombia 39
LT - Lituania 37
VE - Venezuela 36
AU - Australia 35
CL - Cile 35
AT - Austria 33
CZ - Repubblica Ceca 33
PH - Filippine 33
PK - Pakistan 32
UZ - Uzbekistan 30
SA - Arabia Saudita 24
IR - Iran 23
JO - Giordania 23
PE - Perù 23
MA - Marocco 22
PY - Paraguay 21
AZ - Azerbaigian 20
DZ - Algeria 19
EG - Egitto 19
IL - Israele 18
NP - Nepal 18
PT - Portogallo 18
TH - Thailandia 16
GR - Grecia 15
TN - Tunisia 15
JM - Giamaica 14
KE - Kenya 14
TW - Taiwan 14
NO - Norvegia 13
CR - Costa Rica 12
EU - Europa 12
AL - Albania 11
BO - Bolivia 11
BH - Bahrain 10
KG - Kirghizistan 9
RS - Serbia 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
SY - Repubblica araba siriana 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
CY - Cipro 7
ET - Etiopia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
HU - Ungheria 6
MK - Macedonia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
GT - Guatemala 5
KZ - Kazakistan 5
PA - Panama 5
PS - Palestinian Territory 5
SN - Senegal 5
CI - Costa d'Avorio 4
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
LK - Sri Lanka 4
MD - Moldavia 4
NI - Nicaragua 4
AO - Angola 3
BB - Barbados 3
Totale 48.661
Salva come PNG Salva come JPEG
Città #
Southend 3.859
Santa Clara 1.904
Ashburn 1.879
Singapore 1.864
Stockholm 1.798
Fairfield 1.791
Chandler 1.194
Hong Kong 1.114
Woodbridge 1.107
Houston 1.080
Hefei 927
Jacksonville 818
San Jose 797
Ann Arbor 621
Seattle 600
Wilmington 591
Dearborn 574
Cambridge 568
Nyköping 555
London 548
Beijing 527
Helsinki 468
Rome 375
Ho Chi Minh City 365
Seoul 335
Chicago 305
Los Angeles 297
Milan 289
Dallas 276
The Dalles 246
Modena 245
Hanoi 234
Council Bluffs 230
Berlin 212
Izmir 196
San Diego 186
Princeton 181
New York 172
Sofia 169
Eugene 150
Munich 147
Lauterbourg 142
São Paulo 118
Moscow 115
Shanghai 108
Bologna 93
Buffalo 93
Bremen 89
Jakarta 89
Salt Lake City 87
Orem 83
Naples 79
Des Moines 75
Frankfurt am Main 73
Parma 70
Brussels 68
Columbus 68
Phoenix 66
Palermo 65
Rimini 65
Warsaw 60
Florence 59
Toronto 57
Amsterdam 55
Tokyo 54
Verona 54
Redwood City 53
Chennai 51
Montreal 50
Yalova 50
Dublin 49
Falls Church 49
Da Nang 46
Bari 45
Rio de Janeiro 44
Catania 42
Haiphong 42
Johannesburg 41
Mexico City 39
Turin 38
Fremont 37
Tampa 37
Guangzhou 35
Turku 35
Denver 33
Manchester 33
Mumbai 33
Padova 32
Paris 32
Elk Grove Village 31
Poplar 30
Dhaka 29
Kunming 29
Atlanta 28
Boardman 28
Brooklyn 28
Baghdad 26
Belo Horizonte 26
Brasília 26
Tashkent 26
Totale 33.032
Salva come PNG Salva come JPEG
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 2.427
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.810
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 699
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 686
Validating the Body Uneasiness Test (BUT) in obese patients 676
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 635
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 575
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 563
Oxford Manuale di Medicina Clinica 524
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 491
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 491
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 479
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 473
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 458
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 420
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 409
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 400
Acute Intermittent Porphyria in a Child with Severe Neuropathy 397
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 380
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 376
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 373
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 370
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 363
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 348
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 343
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 338
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 338
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 330
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 328
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 327
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 322
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 321
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 315
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 312
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 311
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 310
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 309
Drugs and acute porphyrias: reasons for a hazardous relationship 306
A large deletion on chromosome 11 in acute intermittent porphyria 301
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 300
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 298
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 296
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 293
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 292
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 287
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 286
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 286
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 283
The Metabolic Syndrome in Treatment-Seeking Obese Persons 282
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 280
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 279
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 278
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 277
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 277
Affinità dell'omocisteina per le lipoproteine 274
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 273
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 273
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 269
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 266
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 266
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 265
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 264
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 259
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 259
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 258
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 258
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 258
Psychological Distress in Morbid Obesity in Relation to Weight History 257
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 255
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 254
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 252
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 249
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 247
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 247
Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia ? 245
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 245
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 239
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 239
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 239
Plasma nitric oxide production during acute hyperhomocysteinemia in atherosclerotic patients and controls 237
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 237
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 237
Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension 235
Impact of nutrition on cognition and affectivity in the elderly: A review 234
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 234
Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate 233
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 232
Rilevanza del diverso contenuto apolipoproteico nel legame dell’omocisteina alle lipoproteine 230
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 230
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 229
Construct Validity of the Short Form-36 Health Survey and Its Relationship with BMI in Obese Outpatients 229
When awareness makes the difference: diagnosing and treating the acute hepatic porphyrias 229
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 228
Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report 227
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 227
Porfiria acuta intermittente: un caso "eccezionale" 227
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 225
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 223
Sarcoma primitivo del cuore. Descrizione di un caso 221
Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C 220
Totale 35.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.105 0 0 0 0 0 0 0 0 0 459 347 299
2021/20223.669 178 412 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20258.142 322 149 325 583 1.543 1.083 598 494 885 337 858 965
2025/202615.154 1.010 748 1.368 1.491 1.785 1.117 1.782 828 3.445 1.580 0 0
Totale 49.005